Hepatitis C in HIV-infected individuals: Cure and control, right now

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Thomas, David L ^a   Leoutsakas, Dennis ^b   Zabransky, Tomas ^c   Kumar, M Suresh ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SALISBURY UNIVERSITY   (United States)

^c CHARLES UNIVERSITY   (Czech Republic)

^d YR Gaitonde Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN; ANTIVIRUS AGENT;

HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MIXED INFECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VIRUS LOAD; VIRUS TRANSMISSION; AIDS RELATED COMPLEX;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; HEPATITIS C; HIV INFECTIONS; HUMANS;

EID: 79955660232     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-22     Document Type: Review

References (47)

1. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. JK Rockstroh A Mocroft V Soriano C Tural MH Losso A Horban O Kirk A Phillips B Ledergerber J Lundgren, J Infect Dis 2005 192 992 1002 (Pubitemid 41266795)
2. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. N Abdala JM Carney AJ Durante N Klimov D Ostrovski AM Somlai A Kozlov R Heimer, Int J STD AIDS 2003 14 697 703 (Pubitemid 37193978)
3. Correlates of hepatitis C virus infections among injection drug users in Baltimore. DL Thomas D Vlahov L Solomon S Cohn E Taylor R Garfein KE Nelson, Medicine 1995 74 212 220
4. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. D Lincoln K Petoumenos GJ Dore, HIV Med 2003 4 241 249 (Pubitemid 36949880)
5. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. SS Solomon AK SriKrishnan SH Mehta CK Vasudevan KG Murugavel E Thamburaj S Anand MS Kumar C Latkin S Solomon DD Celentano, J Acquir Immune Defic Syndr 2008 49 327 332
6. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. VM Quan VF Go LV Nam A Bergenstrom NP Thuoc J Zenilman C Latkin DD Celentano, AIDS Care 2009 21 7 16
7. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. Y Tan QH Wei LJ Chen PC Chan WS Lai ML He HF Kung SS Lee, PLoS ONE 2008 3 3608
8. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. RJ Garten S Lai J Zhang W Liu J Chen D Vlahov XF Yu, Int J Epidemiol 2004 33 182 188 (Pubitemid 38500175)
9. Acute hepatitis C virus infection in incarcerated injection drug users. BH McGovern A Wurcel AY Kim WJ Schulze zur I Bica MT Zaman J Timm BD Walker GM Lauer, Clin Infect Dis 2006 42 1663 1670 (Pubitemid 43839427)
10. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. DS Holsen S Harthug H Myrmel, Eur J Clin Microbiol Infect Dis 1993 12 673 676 (Pubitemid 23293225)
11. Hepatitis C in the HIV-infected patient. MS Sulkowski DL Thomas, Clin Liver Dis 2003 7 179 194 (Pubitemid 36350759)
12. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. M Danta D Brown S Bhagani OG Pybus CA Sabin M Nelson M Fisher AM Johnson GM Dusheiko, AIDS 2007 21 983 991 (Pubitemid 46684329)
13. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. DS Fierer AJ Uriel DC Carriero A Klepper DT Dieterich MP Mullen SN Thung MI Fiel AD Branch, J Infect Dis 2008 198 683 686
14. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. T van de Laar O Pybus S Bruisten D Brown M Nelson S Bhagani M Vogel A Baumgarten ML Chaix M Fisher H Gotz GV Matthews S Neifer P White W Rawlinson S Pol J Rockstroh R Coutinho GJ Dore GM Dusheiko M Danta, Gastroenterology 2009 136 1609 1617
15. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. JL Gerberding, J Infect Dis 1994 170 1410 1417
16. Reconstruction of the Hepatitis C Virus Epidemic in the US Hemophilia Population, 1940-1990. JJ Goedert BE Chen L Preiss LM Aledort PS Rosenberg, Am J Epidemiol 2007
17. Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. JR Ticehurst FM Hamzeh DL Thomas, J Clin Microbiol 2007 45 2426 2433 (Pubitemid 47295469)
18. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. JW Mellors CRJ Rinaldo P Gupta RM White JA Todd LA Kingsley, Science 1996 272 1167 1170 (Pubitemid 26001148)
19. The injection century: massive unsterile injections and the emergence of human pathogens. E Drucker PG Alcabes PA Marx, Lancet 2001 358 1989 1992 (Pubitemid 34072887)
20. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. G Magiorkinis E Magiorkinis D Paraskevis SY Ho B Shapiro OG Pybus JP Allain A Hatzakis, PLoS Med 2009 6 1000198
21. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. C Frank MK Mohamed GT Strickland D Lavanchy RR Arthur LS Magder T El Khoby Y Abdel-Wahab ES Aly Ohn W Anwar I Sallam, Lancet 2000 355 887 891 (Pubitemid 30137669)
22. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. RS Garfein MC Doherty ER Monterroso DL Thomas KE Nelson D Vlahov, J Acquir Immune Defic Syndr Hum Retrovirol 1998 18 Suppl 1 11 S19
23. Evolution of the human immunodeficiency virus epidemic among patients attending sexually transmitted disease clinics: a decade of experience. TC Quinn SL Groseclose M Spence V Provost EW Hook III, J Infect Dis 1992 165 541 544
24. Hepatitis B and hepatitis C in emergency department patients. GD Kelen GB Green RH Purcell DW Chan BF Qaqish KT Sivertson TC Quinn, N Engl J Med 1992 326 1399 1404
25. The natural history of hepatitis C virus infection: host, viral, and environmental factors. DL Thomas J Astemborski RM Rai FA Anania M Schaeffer N Galai K Nolt KE Nelson SA Strathdee L Johnson O Laeyendecker J Boitnott LE Wilson D Vlahov, JAMA 2000 284 450 456 (Pubitemid 30484478)
26. Determinants of the quantity of hepatitis C virus RNA. DL Thomas J Astemborski D Vlahov SA Strathdee SC Ray KE Nelson N Galai KR Nolt O Laeyendecker JA Todd, J Infect Dis 2000 181 844 851 (Pubitemid 30194464)
27. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. FJ Torriani M Rodriguez-Torres JK Rockstroh E Lissen J Gonzalez-Garcia A Lazzarin G Carosi J Sasadeusz C Katlama J Montaner H Sette S Passe J De Pamphilis F Duff UM Schrenk DT Dieterich, N Engl J Med 2004 351 438 450 (Pubitemid 38988593)
28. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. SJ Hadziyannis H Sette TR Morgan V Balan M Diago P Marcellin G Ramadori H Bodenheimer D Bernstein M Rizzetto S Zeuzem PJ Pockros A Lin AM Ackrill, Ann Intern Med 2004 140 346 355
29. Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta-analysis. CS Graham LR Baden E Yu JM Mrus J Carnie T Heeren MJ Koziel, Clin Infect Dis 2001 33 562 569 (Pubitemid 32709592)
30. End-stage liver disease in persons with hemophilia and transfusion- associated infections. JJ Goedert ME Eyster MM Lederman T Mandalaki P De Moerloose GC White AL Angiolillo NL Luban KE Sherman M Manco-Johnson L Preiss C Leissinger CM Kessler AR Cohen D DiMichele MW Hilgartner LM Aledort BL Kroner PS Rosenberg A Hatzakis, Blood 2002 100 1584 1589 (Pubitemid 34925132)
31. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. RT Chung SR Evans Y Yang D Theodore H Valdez R Clark C Shikuma T Nevin KE Sherman AIDS Clinical Trials Groups 383 Study Team, AIDS 2002 16 1915 1923
32. Survival of persons with and without HIV infection in Denmark, 1995-2005. N Lohse AB Hansen G Pedersen G Kronborg J Gerstoft HT Sorensen M Vaeth N Obel, Ann Intern Med 2007 146 87 95 (Pubitemid 351640011)
33. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. R Weber CA Sabin N Friis-Moller P Reiss WM El Sadr O Kirk F Dabis MG Law C Pradier S De Wit B Akerlund G Calvo A Monforte M Rickenbach B Ledergerber AN Phillips JD Lundgren, Arch Intern Med 2006 166 1632 1641 (Pubitemid 44232373)
34. Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection. I Bica B McGovern R Dhar D Stone K McGowan R Scheib DR Snydman, Clin Infect Dis 2001 32 492 497 (Pubitemid 32173638)
35. Psychosocial issues in hepatitis C: a qualitative analysis. EA Janke S McGraw G Garcia-Tsao L Fraenkel, Psychosomatics 2008 49 494 501
36. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. F Marcellin M Preau I Ravaux P Dellamonica B Spire MP Carrieri, HIV Clin Trials 2007 8 320 327 (Pubitemid 350103429)
37. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. FJ Mahoney K Stewart HX Hu P Coleman MJ Alter, Arch Intern Med 1997 157 2601 2605 (Pubitemid 27519980)
38. Europeans AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. JK Rockstroh S Bhagani Y Benhamou R Bruno S Mauss L Peters M Puoti V Soriano C Tural, HIV Med 2008 9 82 88 (Pubitemid 351228130)
39. Diagnosis, management, and treatment of hepatitis C: An update. MG Ghany DB Strader DL Thomas LB Seeff, Hepatology 2009 49 4 1335 1374
40. Guidelines for Preventing Opportunistic Infections in HIV-Infected Adults and Adolescents - Recommendations from the CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Centers for Disease Control and Prevention, MMWR 2009 58 1 206
41. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. J Zhou GJ Dore F Zhang PL Lim YM Chen, J Gastroenterol Hepatol 2007 22 1510 1518 (Pubitemid 47274591)
42. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. SR Lee GD Yearwood GB Guillon LA Kurtz M Fischl T Friel CA Berne KW Kardos, J Clin Virol 2010 48 15 17
43. Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies. V Soriano I Maida M Nunez J Garcia-Samaniego P Barreiro L Martin-Carbonero J Gonzalez-Lahoz, Antivir Ther 2004 9 987 992 (Pubitemid 40040272)
44. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. J Berenguer J Alvarez-Pellicer PM Martin J Lopez-Aldeguer MA Von-Wichmann C Quereda J Mallolas J Sanz C Tural JM Bellon J Gonzalez-Garcia, Hepatology 2009 50 407 413
45. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. JG McHutchison GT Everson SC Gordon IM Jacobson M Sulkowski R Kauffman L McNair J Alam AJ Muir, N Engl J Med 2009 360 1827 1838
46. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. SA Villano D Vlahov KE Nelson CM Lyles S Cohn DL Thomas, J Clin Microbiol 1997 35 3274 7 (Pubitemid 27505758)
47. Curing hepatitis C with pills: a step toward global control. DL Thomas, Lancet 2010 376 1441 2